"Thrombosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formation and development of a thrombus or blood clot in the blood vessel.
| Descriptor ID |
D013927
|
| MeSH Number(s) |
C14.907.355.830
|
| Concept/Terms |
Thrombus- Thrombus
- Blood Clot
- Blood Clots
- Clot, Blood
- Clots, Blood
|
Below are MeSH descriptors whose meaning is more general than "Thrombosis".
Below are MeSH descriptors whose meaning is more specific than "Thrombosis".
This graph shows the total number of publications written about "Thrombosis" by people in this website by year, and whether "Thrombosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 4 | 0 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 4 | 2 | 6 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 0 | 1 |
| 2021 | 2 | 1 | 3 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombosis" by people in Profiles.
-
Afosah DK, Ofori E, Mottamal M, Al-Horani RA. Factor IX(a) inhibitors: an updated patent review (2003-present). Expert Opin Ther Pat. 2022 Apr; 32(4):381-400.
-
Vaithilingam S, Habash F, Lopez-Candales A, Venkata AN. An Intruder in the Heart. Chest. 2021 06; 159(6):e429-e431.
-
Lazaridis D, Leung S, Kohler L, Smith CH, Kearson ML, Eraikhuemen N. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review. J Pharm Pract. 2022 Dec; 35(6):1000-1006.
-
Eraikhuemen N, Lazaridis D, Dutton MT. Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels. Am J Cardiovasc Drugs. 2021 May; 21(3):255-265.
-
Gordeuk VR. Sickle cell vaso-occlusion: the clot thickens. Blood. 2020 05 14; 135(20):1726-1727.
-
Srisuwananukorn A, Raslan R, Zhang X, Shah BN, Han J, Gowhari M, Molokie RE, Gordeuk VR, Saraf SL. Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease. Blood Adv. 2020 05 12; 4(9):1978-1986.
-
Gordeuk VR, Miasnikova GY, Sergueeva AI, Lorenzo FR, Zhang X, Song J, Stockton DW, Prchal JT. Thrombotic risk in congenital erythrocytosis due to up-regulated hypoxia sensing is not associated with elevated hematocrit. Haematologica. 2020 03; 105(3):e87-e90.
-
Al-Horani RA, Clemons D, Mottamal M. The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis. Molecules. 2019 Jun 06; 24(11).
-
Gordeuk VR, Key NS, Prchal JT. Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis. Haematologica. 2019 04; 104(4):653-658.
-
Liang W, Fan Y, Lu H, Chang Z, Hu W, Sun J, Wang H, Zhu T, Wang J, Adili R, Garcia-Barrio MT, Holinstat M, Eitzman D, Zhang J, Chen YE. KLF11 (Kr?ppel-Like Factor 11) Inhibits Arterial Thrombosis via Suppression of Tissue Factor in the Vascular Wall. Arterioscler Thromb Vasc Biol. 2019 03; 39(3):402-412.